CardioNerds SCAI

Welcome to the CardioNerds at SCAI SHOCK 2022 Knowledge Hub, powered by CardioNerds. We’ll deliver in-depth video interviews with key opinion leaders in the cardiology space, featuring the latest data on enhancing multidisciplinary care in cardiogenic shock and highlights from the 2022 conference, taking place October 13-15 in Minneapolis, Minnesota.

Featured Videos

CardioNerds at SCAI SHOCK 2022: The FLAME Trial

video
In the FlowTriever for Acute Massive Pulmonary Embolism (FLAME) study, researchers aimed to assess treatment outcomes of patients diagnosed with high-risk (massive) pulmonary embolism. In this video interview, CardioNerds correspondents Drs. Saahil Jumkhawala (Rutgers Medical School), and Nazli Okumus (Allegheny Health Network) spoke with the...

CardioNerds at SCAI SHOCK 2022: CVAD Shock

video
Cardiogenic shock is challenging to treat, and traditionally results in poor outcomes. Therefore, it is critical to identify such patients early and treat them effectively. The National Cardiogenic Shock Iniative (NCSI), started in Detroit, uses an algorithm to manage patients with acute myocardial infarction...

CardioNerds at SCAI SHOCK 2022: The ISO-Shock Trial

video
The Incorporating SuperSaturated Oxygen in Shock (ISO-Shock) study assessed the safety and efficacy of TherOx SuperSaturated Oxygen (SSO2) in patients with ST Elevation Myocardial Infarction (STEMI) and cardiogenic shock treated with mechanical circulatory support. In this video interview, Drs. Carrie Mahurin (University of Vermont) and...

CardioNerds at SCAI SHOCK 2022: The Cardiogenic Shock Working Group Registry

video
The Cardiogenic Shock Working Group (CSWG) is a multicenter registry developed to collate clinical data on shock patients from various institutions with the goal of centralizing the data for analysis to yield better outcomes. In this video interview, Drs. Carrie Mahurin (University of Vermont), and...

CardioNerds at SCAI SHOCK 2022: America vs Europe in Cardiogenic Shock

video
Cardiogenic shock treatment in the United States has changed as novel therapies and innovative devices have emerged in the last few decades. But how has treatment progressed overseas? In this interview, Drs. Nazli Okumus (Allegheny Health Network), and Aman Kansal (Duke University) of the CardioNerds...

CardioNerds at SCAI SHOCK 2022: The National Cardiogenic Shock Initiative

video
The National Cardiogenic Shock Initiative (NCSI) aims to bring together centers from across the U.S. that specialize in mechanical reperfusion therapies and possess extensive experience in using mechanical circulatory support devices to optimize care in patients with acute myocardial infarction complicated by cardiogenic shock...

CardioNerds at SCAI SHOCK 2022: The RECOVER IV Trial

video
The RECOVER IV trial is a two-arm study that seeks to analyze whether percutaneous coronary intervention (PCI) with Impella® heart pumps used prior to PCI is superior to PCI without Impella support. In this video interview, Drs. Nick Smith (Johns Hopkins Hospital) and Gurleen Kaur...

CardioNerds at SCAI SHOCK 2022: CAPITAL DOREMI 2

video
The CAPITAL DOREMI 2 study is a multi-centre, double-blind, randomized controlled trial which assessed the safety and efficacy of inotrope therapy versus placebo in treating patients with SCAI class C to D cardiogenic shock. In this video interview, Drs. Nick Smith (Johns Hopkins Hospital) and...

CardioNerds at SCAI SHOCK 2022: The DanGer Shock Trial

video
The recent DanGer Shock trial sought to assess if the use of left ventricular mechanical circulatory support using Impella CP transvalvular microaxial flow pump enhances survival in patients with cardiogenic shock. In this interview, Drs. Nazli Okumus and Saahil Jumkhawala of the CardioNerds spoke with...

CardioNerds at SCAI SHOCK 2022: The PACCS Trial

PA-Catheter in Cardiogenic Shock (PACCS)video
The Pulmonary Artery Catheter in Cardiogenic Shock Trial (PACCS) was conducted to analyze if early invasive hemodynamic assessment and ongoing management with a PAC in cardiogenic shock patients is associated with lower in-hospital mortality compared to standard of care. In this interview, Drs. Nick Smith...

CardioNerds at SCAI SHOCK 2022: The VANQUISH Shock Registry

VANQUISH Shock Registryvideo
Despite advances in treatment, cardiogenic shock (CS) outcomes remain dire. As such, researchers initiated the Multicenter Collaborative to Enhance Biological Understanding, Quality and Outcomes in Cardiogenic Shock registry (VANQUISH Shock), which aims to assess unrestricted adult patients with CS at several North American centers. In...

CardioNerds at SCAI SHOCK 2022: The AHA Cardiogenic Shock Registry

AHA Cardiogenic Shock Registryvideo
The American Heart Association (AHA) recently created the Cardiogenic Shock Registry to enhance the quality of care and understanding of patients presenting with cardiogenic shock across the United States. According to the AHA, a few aims of the registry include: Provide high-quality evidence that...

Meet The NERDS!

Advertisement
Advertisement

More from CardioNerds